Novel vancomycin resistance gene cluster in


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
09 2021
Historique:
entrez: 10 9 2021
pubmed: 11 9 2021
medline: 14 9 2021
Statut: ppublish

Résumé

We identified a novel

Identifiants

pubmed: 34505571
doi: 10.2807/1560-7917.ES.2021.26.36.2100767
pmc: PMC8431993
doi:

Substances chimiques

Anti-Bacterial Agents 0
Bacterial Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

ISME J. 2015 Jan;9(1):207-16
pubmed: 25003965
Antimicrob Agents Chemother. 2016 Jun 20;60(7):4119-27
pubmed: 27139479
Nucleic Acids Res. 2019 Jan 8;47(D1):D660-D665
pubmed: 30407568
Antimicrob Agents Chemother. 2014;58(3):1768-70
pubmed: 24342631
Future Microbiol. 2017 Feb;12:157-170
pubmed: 28139139
Clin Microbiol Rev. 2019 Jan 30;32(2):
pubmed: 30700430
Lancet Infect Dis. 2018 Mar;18(3):318-327
pubmed: 29276051
Antimicrob Resist Infect Control. 2020 Aug 10;9(1):130
pubmed: 32778149
mBio. 2014 Jul 22;5(4):e01386-14
pubmed: 25053786
J Biol Chem. 2012 Nov 2;287(45):37583-92
pubmed: 22969085
Genome Res. 2018 Sep;28(9):1395-1404
pubmed: 30049790
Mol Biol Evol. 2018 Jun 1;35(6):1547-1549
pubmed: 29722887
Nucleic Acids Res. 2016 Jul 8;44(W1):W16-21
pubmed: 27141966
Microb Genom. 2018 Mar;4(3):
pubmed: 29543149
iScience. 2020 Jan 24;23(1):100769
pubmed: 31887656
mBio. 2012 Jul 17;3(4):e00151-12
pubmed: 22807567
Lancet Infect Dis. 2001 Dec;1(5):314-25
pubmed: 11871804
Microb Drug Resist. 2018 Jun;24(5):590-606
pubmed: 29058560

Auteurs

Basil Britto Xavier (BB)

Laboratory of Medical Microbiology, Universiteit Antwerpen, Wilrijk, Belgium.
Vaccine and Infectious Disease Institute, Universiteit Antwerpen, Wilrijk, Belgium.

Jasmine Coppens (J)

Laboratory of Clinical Microbiology, Antwerp University Hospital, Edegem, Belgium.

Sien De Koster (S)

Laboratory of Medical Microbiology, Universiteit Antwerpen, Wilrijk, Belgium.
Vaccine and Infectious Disease Institute, Universiteit Antwerpen, Wilrijk, Belgium.

Sahaya Glingston Rajakani (SG)

Laboratory of Medical Microbiology, Universiteit Antwerpen, Wilrijk, Belgium.
Vaccine and Infectious Disease Institute, Universiteit Antwerpen, Wilrijk, Belgium.

Sam Van Goethem (S)

Laboratory of Clinical Microbiology, Antwerp University Hospital, Edegem, Belgium.

Samy Mzougui (S)

Laboratory of Clinical Microbiology, Cliniques Universitaires Saint-Luc-UCLouvain, Brussels, Belgium.

Ahalieyah Anantharajah (A)

Laboratory of Clinical Microbiology, Cliniques Universitaires Saint-Luc-UCLouvain, Brussels, Belgium.

Christine Lammens (C)

Laboratory of Medical Microbiology, Universiteit Antwerpen, Wilrijk, Belgium.
Vaccine and Infectious Disease Institute, Universiteit Antwerpen, Wilrijk, Belgium.

Katherine Loens (K)

Laboratory of Clinical Microbiology, Antwerp University Hospital, Edegem, Belgium.
Belgian National Reference Centre for Enterococci, Antwerp University Hospital, Edegem, Belgium.

Youri Glupczynski (Y)

Laboratory of Medical Microbiology, Universiteit Antwerpen, Wilrijk, Belgium.
Vaccine and Infectious Disease Institute, Universiteit Antwerpen, Wilrijk, Belgium.

Herman Goossens (H)

Laboratory of Medical Microbiology, Universiteit Antwerpen, Wilrijk, Belgium.
Vaccine and Infectious Disease Institute, Universiteit Antwerpen, Wilrijk, Belgium.
Laboratory of Clinical Microbiology, Antwerp University Hospital, Edegem, Belgium.
Belgian National Reference Centre for Enterococci, Antwerp University Hospital, Edegem, Belgium.

Veerle Matheeussen (V)

Laboratory of Clinical Microbiology, Antwerp University Hospital, Edegem, Belgium.
Belgian National Reference Centre for Enterococci, Antwerp University Hospital, Edegem, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH